Caption Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$883K	Buy	+45,127	New	+$1.34M	0.04%	1062
2025 Q4	–	Sell	-8,956	Closed	-$193K	–	2452
2025 Q3	$193K	Buy	+8,956	New	+$162K	0.01%	1474
2025 Q2	–	Hold	0	–	–	–	2266
2025 Q1	–	Sell	-56,760	Closed	-$967K	–	2432
2024 Q4	$1.09M	Buy	+56,760	New	+$1.23M	0.04%	891
2024 Q3	–	Sell	-44,300	Closed	-$724K	–	1904
2024 Q2	$576K	Buy	44,300 +19,300	+77%	+$267K	0.06%	783
2024 Q1	$438K	Buy	+25,000	New	+$485K	0.05%	900
2023 Q3	–	Sell	-36,000	Closed	-$856K	–	1863
2023 Q2	$856K	Buy	36,000 +21,000	+140%	+$539K	0.15%	697
2023 Q1	$382K	Buy	+15,000	New	+$481K	0.08%	840
2022 Q3	–	Sell	-17,777	Closed	-$206K	–	2122
2022 Q2	$206K	Buy	+17,777	New	+$239K	0.02%	1232
2022 Q1	–	Hold	0	–	–	–	2285
2021 Q4	–	Hold	0	–	–	–	2230
2021 Q3	–	Hold	0	–	–	–	2132